APMA has the resources you need to help you through every step of your career. With detailed information about MIPS and recent coding trends along with compliance guidelines and practice marketing materials, APMA has you covered whether you are just getting started in practice, preparing for retirement, or anywhere in between.
Today's podiatrist has the necessary education and training to treat all conditions of the foot and ankle and plays a key role in keeping America healthy and mobile while helping combat diabetes and other chronic diseases.
Your feet are excellent barometers for your overall health. Healthy feet keep you moving and active. They are quite literally your foundation. In this section, learn more about APMA Seal-approved and accepted products, proper foot care, common foot and ankle conditions, and how your podiatrist can help keep you and your feet healthy.
APMA is the only organization lobbying for podiatrists and their patients on Capitol Hill. As the voice of podiatric medicine to your legislators and regulators, APMA is active on a variety of critical issues affecting podiatry and the entire health-care system.
The latest issue of JAPMA is the first of three installments dedicated to the opioid crisis. This first issue focuses on opioid problems within the profession. The next issue will focus on opioid solutions, and the third will present opioid prescribing pearls.
Articles from Brandon Brooks, DPM, MPH, and Robert Smith, DPM, MSc, RPh, FNAP, highlight prescribing practices of podiatrists, including a look at cognitive bias in postoperative opioid prescribing practices, the diabetic foot-pain-depression cycle, and opioid treatment agreements.
In discussing the new DEA MATE training list, Dr. Brooks notes that because DPMs have been excluded from the list of approved CME providers, he “hopes that these opioid editions in JAPMA can highlight our profession’s opioid research (which includes several novel concepts and solutions to the current opioid crisis) in order to demonstrate that we are here to help resolve this public health crisis and worthy of inclusion.”
Dr. Smith notes that “These two topics have not been explored fully within the context of our profession. … Both opioid use treatment agreements and dosing opioid analgesics overshadowed by substance use disorder are paramount to preventing opioid harm.”
Learn More About APMA/TDI Public Health Fellowship at August 29 Q&A
—
Learn MoreAPMA/TDI Public Health Fellowship–Call for Applicants
—
Learn More11400 Rockville Pike, Suite 220
Rockville, MD 20852
301-581-9200
Contact Us
Copyright © 2024 American Podiatric Medical Association